MariTime-CV is a Phase 3 study for people living with a cardiovascular condition and overweight or obesity.
Learn about MariTime-CV (TIMI 80) from the trial Principal Investigators
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School